Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

ASH 2017

All Publications

Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)

Clinical Imetelstat: MDS Imetelstat

Fenaux P, et al.

Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Hematopoietic Stem Cells and Progenitor Cells

Imetelstat Non-clinical Imetelstat

Hu C, et al.

Telomerase Inhibition Impairs Self-Renewal of b-Catenin Activated Myeloproliferative Neoplasm Progenitors

Imetelstat Non-clinical Imetelstat

Ma W, et al.

Integrated Molecular Analysis Identifies Replicative Stress as Sensitizer to Imetelstat Therapy in AML

Imetelstat Non-clinical Imetelstat

Bruedigam C, et al.

[facetwp facet="publication_load_more"]